Genomtec has successfully completed the expansion of its Genomtec ID platform in the field of oncological diagnostics and has filed a patent application for a new method developed by the company. This method involves isothermal amplification of nucleic acids for the detection of genetic variants used in oncological diagnostics.
“We are very pleased that the fast pace of work by the entire Genomtec team has allowed us to transition from the ideation stage to the formulation of a patent application and achieve an important milestone in just a few months. Now, we are not far from the Proof-of-Concept stage. I believe that the potential scope of implementing our technology is not limited to the areas of upper respiratory tract disease diagnostics or oncology, which are already some of the most attractive segments of the diagnostics market. Furthermore, the technology we are developing may be utilized in drug development, companion diagnostics, drug dosing, virus variant identification, drug-resistant bacterial strain research, as well as in veterinary medicine and the food industry.” – said Dr Miron Tokarski, CEO Genomtec S.A.
